Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Systems have been put in place in the Mayo Clinic Stem Cell Transplantation program to reduce day-100 all-cause mortality. Currently our mortality has been reduced to 0.3%. Patients can undergo transplant as an outpatient, with a median hospital duration of 0 days and only 25% of patients requiring a hospital stay of 5 days or greater. Outpatient transplantation is safe and reduces patient-incurred costs.

Original languageEnglish (US)
Pages (from-to)56-58
Number of pages3
JournalMayo Clinic Proceedings
Volume93
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Multiple Myeloma
Stem Cells
Transplants
Safety
Outpatients
Mortality
Stem Cell Transplantation
Length of Stay
Transplantation
Costs and Cost Analysis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{e140506f37774aafa5c48625faa1c240,
title = "Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma",
abstract = "Systems have been put in place in the Mayo Clinic Stem Cell Transplantation program to reduce day-100 all-cause mortality. Currently our mortality has been reduced to 0.3{\%}. Patients can undergo transplant as an outpatient, with a median hospital duration of 0 days and only 25{\%} of patients requiring a hospital stay of 5 days or greater. Outpatient transplantation is safe and reduces patient-incurred costs.",
author = "Morie Gertz and Buadi, {Francis K.} and Hayman, {Suzanne R.} and Martha Lacy and Angela Dispenzieri and Dingli, {David M} and Wilson Gonsalves and Kumar, {Shaji K} and Prashant Kapoor and Taxiarchis Kourelis and William Hogan",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.mayocp.2017.09.012",
language = "English (US)",
volume = "93",
pages = "56--58",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "1",

}

TY - JOUR

T1 - Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma

AU - Gertz, Morie

AU - Buadi, Francis K.

AU - Hayman, Suzanne R.

AU - Lacy, Martha

AU - Dispenzieri, Angela

AU - Dingli, David M

AU - Gonsalves, Wilson

AU - Kumar, Shaji K

AU - Kapoor, Prashant

AU - Kourelis, Taxiarchis

AU - Hogan, William

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Systems have been put in place in the Mayo Clinic Stem Cell Transplantation program to reduce day-100 all-cause mortality. Currently our mortality has been reduced to 0.3%. Patients can undergo transplant as an outpatient, with a median hospital duration of 0 days and only 25% of patients requiring a hospital stay of 5 days or greater. Outpatient transplantation is safe and reduces patient-incurred costs.

AB - Systems have been put in place in the Mayo Clinic Stem Cell Transplantation program to reduce day-100 all-cause mortality. Currently our mortality has been reduced to 0.3%. Patients can undergo transplant as an outpatient, with a median hospital duration of 0 days and only 25% of patients requiring a hospital stay of 5 days or greater. Outpatient transplantation is safe and reduces patient-incurred costs.

UR - http://www.scopus.com/inward/record.url?scp=85040560203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040560203&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2017.09.012

DO - 10.1016/j.mayocp.2017.09.012

M3 - Article

C2 - 29304921

AN - SCOPUS:85040560203

VL - 93

SP - 56

EP - 58

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 1

ER -